Why Transdermal GLP-1 Support Patches
They can help you weigh the benefits and risks and explore alternative strategies if needed
Longer term For longer protocols, review metabolic, IGF-1, kidney, liver, and cardiovascular trends every 3 months with a clinician
Glucagon-like peptide-1 receptor agonists (GLP-1s) have become one of the most widely prescribed medication classes for type 2 diabetes, with more than one in four U.S
For MCAS and year-round histamine issues, longer-term protocols are more common
But if they dont have any of those conditions, I think we should prioritize these newer injectable medications, which are such profound weight loss and metabolic benefits. Majety said the network meta-analysis was comprehensive, but more data are needed to assess the potential loss of lean body mass with obesity medications